One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Elacestrant and the Promise of Oral SERDs.
Sanchez, Katherine G. MD 1,2; Nangia, Julie R. MD 1,2,3; Schiff, Rachel PhD 1,2,3,4; Rimawi, Mothaffar F. MD 1,2,3,
doi : 10.1200/JCO.22.00841
Volume 40(28) pgs. 3227-3351 October 1, 2022
Building on More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals.
Yurgelun, Matthew B. MD 1,
doi : 10.1200/JCO.22.01287
Long-Term Outcomes After Transplantation for Acute Myelogenous Leukemia.
Socie, Gerard MD, PhD 1,
doi : 10.1200/JCO.22.01177
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
Morschhauser, Franck MD, PhD 1,; Nastoupil, Loretta MD 2; Feugier, Pierre MD, PhD 3; Schiano de Colella, Jean-Marc MD 4; Tilly, Herve MD 5; Palomba, Maria Lia MD 6; Bachy, Emmanuel MD, PhD 7; Fruchart, Christophe MD 8; Libby, Edward N. MD 9; Casasnovas, Rene-Olivier MD 10; Flinn, Ian W. MD, PhD 11; Haioun, Corinne MD 12; Maisonneuve, Herve MD 13; Ysebaert, Loic MD, PhD 14; Bartlett, Nancy L. MD 15; Bouabdallah, Kamal MD 16; Brice, Pauline MD 17; Ribrag, Vincent MD 18; Le Gouill, Steven MD, PhD 19; Daguindau, Nicolas MD 20; Guidez, Stephanie MD 21; Pica, Gian Matteo MD 22; Garcia-Sancho, Alejandro Martin MD, PhD 23; Lopez-Guillermo, Armondo MD 24; Larouche, Jean-Francois MD 25; Ando, Kiyoshi MD 26; Gomes da Silva, Maria MD, PhD 27; Andre, Marc MD 28; Kalung, Wu MD 29; Sehn, Laurie H. MD, MPH 30; Izutsu, Koji MD, PhD 31; Cartron, Guillaume MD, PhD 32; Gkasiamis, Argyrios MD 33; Crowe, Russell MA 33; Xerri, Luc MD, PhD 4; Fowler, Nathan H. MD 2; Salles, Gilles MD 6
doi : 10.1200/JCO.22.00843
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Bidard, Francois-Clement MD 1,2; Kaklamani, Virginia G. MD 3; Neven, Patrick MD 4; Streich, Guillermo MD 5; Montero, Alberto J. MD 6; Forget, Frederic MD 7; Mouret-Reynier, Marie-Ange MD 8; Sohn, Joo Hyuk MD 9; Taylor, Donatienne MD 10; Harnden, Kathleen K. MD 11; Khong, Hung MD 12; Kocsis, Judit MD 13; Dalenc, Florence MD 14; Dillon, Patrick M. MD 15; Babu, Sunil MD 16; Waters, Simon MD 17; Deleu, Ines MD 18; Garcia Saenz, Jose A. MD 19; Bria, Emilio MD 20; Cazzaniga, Marina MD 21; Lu, Janice MD 22; Aftimos, Philippe MD 23; Cortes, Javier MD 24,25,26,27; Liu, Shubin MS 28; Tonini, Giulia PhD 29; Laurent, Dirk MD 30; Habboubi, Nassir MD 31; Conlan, Maureen G. MD 32; Bardia, Aditya MD 33,
doi : 10.1200/JCO.22.00338
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.
Dbouk, Mohamad MD 1; Katona, Bryson W. MD 2; Brand, Randall E. MD 3; Chak, Amitabh MD, PhD 4; Syngal, Sapna MD 5,6; Farrell, James J. MD 7; Kastrinos, Fay MD 8; Stoffel, Elena M. MD 9; Blackford, Amanda L. MS 10; Rustgi, Anil K. MD, PhD 7; Dudley, Beth MS 3; Lee, Linda S. MD 5,6; Chhoda, Ankit MD 7; Kwon, Richard MD 9; Ginsberg, Gregory G. MD 2; Klein, Alison P. PhD, MHS 1,10,11,12; Kamel, Ihab MD 10,13; Hruban, Ralph H. MD 1,10; He, Jin MD, PhD 10,14; Shin, Eun Ji MD, PhD 11; Lennon, Anne Marie MB, PhD 10,11,13,14; Canto, Marcia Irene MD, MHS 10,11; Goggins, Michael MB, MD 1,10,11,
doi : 10.1200/JCO.22.00298
Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.
Klatte, Derk C.F. MD 1,; Boekestijn, Bas MD 2; Wasser, Martin N.J.M. MD, PhD 2; Feshtali Shahbazi, Shirin MD 2; Ibrahim, Isaura S. MD 1; Mieog, J. Sven D. MD, PhD 3; Luelmo, Saskia A.C. MD 4; Morreau, Hans MD, PhD 5; Potjer, Thomas P. MD, PhD 6; Inderson, Akin MD 1; Boonstra, Jurjen J. MD, PhD 1; Dekker, Friedo W. PhD 7; Vasen, Hans F.A. MD, PhD 1; van Hooft, Jeanin E. MD, PhD, MBA 1; Bonsing, Bert A. MD, PhD 2; van Leerdam, Monique E. MD, PhD 1,8
doi : 10.1200/JCO.22.00194
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian, Saro H. DO, MPH 1,; Chen, Yanjun MS 2; Hageman, Lindsay BA 2; Wu, Jessica MPH 2; Landier, Wendy PhD 2,3; Bosworth, Alysia BA 1; Francisco, Liton BS 2; Schlichting, Elizabeth BA 2; Bhatia, Ravi MD 4; Salzman, Donna MD 4; Wong, F. Lennie PhD 1; Weisdorf, Daniel J. MD 5; Forman, Stephen J. MD 6; Arora, Mukta MD 5; Bhatia, Smita MD, MPH 2,3
doi : 10.1200/JCO.21.02829
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Thiel, Kristina W. PhD 1; Devor, Eric J. PhD 1; Filiaci, Virginia L. PhD 2; Mutch, David MD 3; Moxley, Katherine MD 4; Alvarez Secord, Angeles MD 5; Tewari, Krishnansu S. MD 6; McDonald, Megan E. MD 1; Mathews, Cara MD 7; Cosgrove, Casey MD 8; Dewdney, Summer MD 9; Aghajanian, Carol MD 10; Samuelson, Megan I. MD 1; Lankes, Heather A. PhD 11; Soslow, Robert A. MD 12; Leslie, Kimberly K. MD 1,12,
doi : 10.1200/JCO.21.02506
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
Agarwal, Neeraj MD 1,; Tangen, Catherine M. DrPH 2; Hussain, Maha H.A. MD 3; Gupta, Shilpa MD 4; Plets, Melissa MS 2; Lara, Primo N. MD 5; Harzstark, Andrea L. MD 6; Twardowski, Przemyslaw W. MD 7; Paller, Channing J. MD 8; Zylla, Dylan MD 9; Zibelman, Matthew R. MD 10; Levine, Ellis MD 11; Roth, Bruce J. MD 12; Goldkorn, Amir MD 13; Vaena, Daniel A. MD 14,15; Kohli, Manish MD 1,16; Crispino, Tony 17; Vogelzang, Nicholas J. MD 18; Thompson, Ian M. Jr MD 19; Quinn, David I. MD 13
doi : 10.1200/JCO.21.02517
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
Singh, Navneet MD, DM 1; Temin, Sarah MSPH 2; Baker, Sherman Jr MD 3; Blanchard, Elizabeth MD 4; Brahmer, Julie R. MD 5; Celano, Paul MD 6; Duma, Narjust MD 7; Ellis, Peter M. MD, PhD 8; Elkins, Ivy B. MBA 9; Haddad, Rami Y. MD 10; Hesketh, Paul J. MD 11; Jain, Dharamvir MD 12; Johnson, David H. MD 13; Leighl, Natasha B. MD 14; Mamdani, Hirva MD 15; Masters, Gregory MD 16; Moffitt, Pamela R. 17; Phillips, Tanyanika MD 18; Riely, Gregory J. MD, PhD 19; Robinson, Andrew G. MD 20; Rosell, Rafael MD 21; Schiller, Joan H. MD 22; Schneider, Bryan J. MD 23; Spigel, David R. MD 24; Jaiyesimi, Ishmael A. MD, MS 25
doi : 10.1200/JCO.22.00824
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
Singh, Navneet MD, DM 1; Temin, Sarah MSPH 2; Baker, Sherman Jr MD 3; Blanchard, Elizabeth MD 4; Brahmer, Julie R. MD 5; Celano, Paul MD 6; Duma, Narjust MD 7; Ellis, Peter M. MD, PhD 8; Elkins, Ivy B. MBA 9; Haddad, Rami Y. MD 10; Hesketh, Paul J. MD 11; Jain, Dharamvir MD 12; Johnson, David H. MD 13; Leighl, Natasha B. MD 14; Mamdani, Hirva MD 15; Masters, Gregory MD 16; Moffitt, Pamela R. 17; Phillips, Tanyanika MD 18; Riely, Gregory J. MD, PhD 19; Robinson, Andrew G. MD 20; Rosell, Rafael MD 21; Schiller, Joan H. MD 22; Schneider, Bryan J. MD 23; Spigel, David R. MD 24; Jaiyesimi, Ishmael A. MD, MS 25
doi : 10.1200/JCO.22.00825
Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer.
Attaallah, Wafi MD
doi : 10.1200/JCO.22.00432
PREOPANC Trial: Survival in the Control Arm and Role of Radiation Need More Explanation.
Jain, Ankit MBBS, MD, DM, DNB; Gananadha, Sivakumar MBBS, MS; Shorthouse, Amy BSc, BMed (Hons); Yip, Desmond MBBS
doi : 10.1200/JCO.22.00538
Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?.
Mroczkowski, Pawel MD, PhD; Zajdel, Radoslaw
doi : 10.1200/JCO.22.00454
Reply to W. Attaallah, A. Jain et al, and P. Mroczkowski et al.
Versteijne, Eva MD, PhD; van Dam, Jacob L. MD; Besselink, Marc G. MD, PhD; Groot Koerkamp, Bas MD, PhD; Homs, Marjolein Y.V. MD, PhD; Wilmink, Johanna W. MD, PhD; van Eijck, Casper H. MD, PhD; van Tienhoven, Geertjan MD, PhD
doi : 10.1200/JCO.22.00875
